Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta leo, ac placerat ex pretium quis.
OSE Immunotherapeutics
Wichita University
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta leo, ac placerat ex pretium quis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed a mi rhoncus, pharetra leo et, efficitur tortor. Fusce vel convallis magna.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta leo, ac placerat ex pretium quis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed a mi rhoncus, pharetra leo et, efficitur tortor. Fusce vel convallis magna, sit amet pulvinar diam. Sed laoreet feugiat consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta leo, ac placerat ex pretium quis.
Our biologists have access to state-of-the-art technologies to validate binding interactions of antibodies to their antigen. MAbSilico is working with 3rd party for antibody production and we can adapt to fulfill your requirements. Our biologists have extensive experience in GPCR, immunology and antibody discovery.
Based on existing data and solutions such as Alphafold, MAbSilico's experts can design by structural homology modeling the 3D template of your target. To anticipate structural modification due to biological context, MAbSilico can model different conformations of your target.
The first information is the target name and its UNIPROT number. These are the only information for antibody de novo design. After an analysis by our structural experts, we can estimate if our technology can be applied to accelerate and increase the success of your project.
If you have already selected antibodies, we need their sequences for the characterization or their optimization.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris rhoncus pharetra cursus. Suspendisse sodales porta leo, ac placerat ex pretium quis.